News for Healthier Living

LifeArc Joins Transatlantic Collaboration to Develop a Treatment for Crimean-Congo Hemorrhagic Fever

A new transatlantic collaboration between the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and LifeArc will look to develop an affordable and accessible monoclonal antibody therapeutic for Crimean-Congo Hemorrhagic Fever Virus (CCHFV), which could treat and protect thousands of people globally.

April 23, 2025


April 23 2025

April 22 2025

April 21 2025

April 19 2025

April 18 2025

April 17 2025

April 16 2025

April 15 2025

April 14 2025

April 12 2025

April 11 2025

April 10 2025